isoptin 180sr verapamil hydrochloride 180mg tablet blister pack
viatris pty ltd - verapamil hydrochloride, quantity: 180 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; sodium alginate; povidone; magnesium stearate; hypromellose; macrogol 400; macrogol 6000; purified talc; glycol/butylene glycol montanate; titanium dioxide; iron oxide red - modified release tablets,isoptin sr is indicated for the management of hypertension and angina pectoris.
isoptin sr verapamil hydrochloride 240mg tablet blister pack
viatris pty ltd - verapamil hydrochloride, quantity: 240 mg - tablet, film coated - excipient ingredients: sodium alginate; powdered cellulose; purified water; magnesium stearate; hypromellose; purified talc; titanium dioxide; povidone; macrogol 400; macrogol 6000; quinoline yellow; indigo carmine; glycol/butylene glycol montanate - isoptin sr (verapamil hydrochloride) is indicated for the management of essential hypertension and angina pectoris.
isoptin verapamil hydrochloride 80mg tablet blister pack
viatris pty ltd - verapamil hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - immediate release tablets,isoptin is indicated for:,-hypertension,- angina of effort,- angina at rest,- vasospastic angina (including prinzmetal?s variant angina),- tachyarrhythmias including paroxysmal supra-ventricular tachycardia,- atrial fibrillation with rapid ventricular response,- atrial flutter with rapid ventricular response
isoptin verapamil hydrochloride 40mg tablet blister pack
viatris pty ltd - verapamil hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - immediate release tablets,isoptin is indicated for:,-hypertension,- angina of effort,- angina at rest,- vasospastic angina (including prinzmetal?s variant angina),- tachyarrhythmias including paroxysmal supra-ventricular tachycardia,- atrial fibrillation with rapid ventricular response,- atrial flutter with rapid ventricular response
isoptin sr 240 mg prolonged-release tablets
mylan ire healthcare limited - verapamil hydrochloride - prolonged-release tablet - 240 milligram(s) - phenylalkylamine derivatives; verapamil - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - mild to moderate hypertension and coronary heart disease, i.e. prophylaxis of myocardial ischaemia, angina pectoris.
isoptin sr 240 mg prolonged-release tablets
viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - prolonged-release tablet - verapamil hydrochloride 240 mg - calcium channel blockers
isoptin 80 milligram film coated tablet
abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 80 milligram
isoptin 40 milligram film coated tablet
abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 40 milligram
isoptin 120 milligram film coated tablet
abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 120 milligram
isoptin sr- verapamil hydrochloride tablet, coated
ranbaxy laboratories inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - tablet, coated - 120 mg - isoptin sr (verapamil hci) is indicated for the management of essential hypertension. verapamil hci is contraindicated in: 1. severe left ventricular dysfunction (see warnings) 2. hypotension (systolic pressure less than 90 mmhg) or cardiogenic shock 3. sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker) 4. second- or third-degree av block (except in patients with a functioning artificial ventricular pacemaker). 5. patients with atrial flutter or atrial fibrillation and an accessory bypass tract (e.g., wolff-parkinson-white, lown-ganong-levine syndromes). (see warnings). 6. patients with known hypersensitivity to verapamil hydrochloride.